HUNTINGTON STATION, NY--(Marketwire - September 05, 2008) - Medivisor, Inc. (PINKSHEETS: MVSR) announced today that it has signed an agreement with Cura Pharmaceutical, Co. Inc to market the product Albumax, a whey protein isolate formula that makes it easy for kidney disorder patients to reach their daily requirements of high quality protein in their diet. Under the terms of the Agreement, Cura will continue to be responsible for manufacturing, regulatory, medical, clinical development, pricing and distribution for the product while Medivisor is responsible for sales and marketing.
